Fifth largest biopharmaceutical firm created by buy-out

Belgium pharmaceutical firm UCB is to buy Britain's largest biotechnology company Celltech for £1.53bn (€2.26bn).

The move gives UCB access to the fast-growing biotechnology market, creating the world's fifth largest biopharmaceutical company.